ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

T Powles, L Albiges + Show 7 more

Open Access

PDF Available

https://doi.org/10.1016/j.annonc.2021.09.014

Copy DOI

Export

Save

Share

Cite

Journal: Annals of Oncology	Publication Date: Sep 28, 2021
Citations: 150	License type: publisher-specific-oa

Affiliation: Queen Mary University of London, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Essen University Hospital, University of Bari Aldo Moro, Fondazione IRCCS Istituto Nazionale dei Tumori, Medical University of Vienna, Vall d'Hebron Institute of Oncology

#Full Text PDF PubMed Scopus #Advanced Renal Cell Carcinoma #ESMO-Magnitude Of Clinical Benefit Scale #Renal Cell Carcinoma #Treatment Of Renal Cell Carcinoma #PubMed Scopus #Google Scholar #Overall Survival Hazard Ratio #Metastatic Renal-cell #Progression-free Survival Hazard Ratio

Abstract
Full-Text PDF
Similar Papers

Abstract

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

Full Text

Published Version (Free)

View/Download pdf

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.